Zura Bio to Present at Three Upcoming Investor Conferences in September
Zura Bio (Nasdaq: ZURA), a clinical-stage immunology company, has announced its participation in three upcoming investor conferences in September 2024. The company will present at the H.C. Wainwright 26th Annual Global Investment Conference on September 11 at 11:30 a.m. ET, the Stifel Immunology and Inflammation Virtual Summit on September 17 at 12:00 p.m. ET, and the Cantor Global Healthcare Conference on September 17 at 2:30 p.m. ET.
Zura Bio's senior leadership team will host investor meetings at these events, with the Stifel summit being virtual. Live webcasts and replays of the presentations will be available on the company's website for at least 30 days following each event.
Zura Bio (Nasdaq: ZURA), un'azienda di immunologia in fase clinica, ha annunciato la sua partecipazione a tre conferenze per investitori che si terranno a settembre 2024. L'azienda presenterà al 26° Conferenza Annuale Mondiale sugli Investimenti H.C. Wainwright l'11 settembre alle 11:30 ET, al Summit Virtuale su Immunologia e Infiammazione Stifel il 17 settembre alle 12:00 ET e al Conferenza Globale sulla Salute di Cantor il 17 settembre alle 14:30 ET.
Il team dirigenziale di Zura Bio ospiterà incontri con gli investitori durante questi eventi, con il summit Stifel che si svolgerà in modalità virtuale. Le dirette web e le riproduzioni delle presentazioni saranno disponibili sul sito web dell'azienda per almeno 30 giorni dopo ciascun evento.
Zura Bio (Nasdaq: ZURA), una empresa de inmunología en etapa clínica, ha anunciado su participación en tres conferencias para inversores que se celebrarán en septiembre de 2024. La empresa presentará en la 26ª Conferencia Anual Global de Inversión de H.C. Wainwright el 11 de septiembre a las 11:30 a.m. ET, en la Cumbre Virtual de Inmunología e Inflamación de Stifel el 17 de septiembre a las 12:00 p.m. ET, y en la Conferencia Global de Salud de Cantor el 17 de septiembre a las 2:30 p.m. ET.
El equipo de alta dirección de Zura Bio organizará reuniones con inversores durante estos eventos, siendo el summit de Stifel virtual. Las transmisiones web en vivo y las repeticiones de las presentaciones estarán disponibles en el sitio web de la empresa durante al menos 30 días después de cada evento.
주라 바이오 (Nasdaq: ZURA), 임상 단계의 면역학 회사가 2024년 9월에 열리는 세 가지 투자자 콘퍼런스에 참여한다고 발표했습니다. 회사는 H.C. 웨인라이트 제26회 글로벌 투자 콘퍼런스에서 9월 11일 오전 11시 30분 ET에 발표할 예정이며, 스티펠 면역학 및 염증 가상 정상 회담에서 9월 17일 낮 12시 ET, 그리고 칸토 글로벌 헬스케어 콘퍼런스에서 9월 17일 오후 2시 30분 ET에 발표할 예정입니다.
주라 바이오의 고위 경영진은 이들 행사 동안 투자자 회의를 주최할 예정이며, 스티펠 정상 회담은 가상으로 진행됩니다. 각 행사 후 최소 30일 동안 회사 웹사이트에서 발표의 생중계와 재생을 이용할 수 있습니다.
Zura Bio (Nasdaq: ZURA), une entreprise d'immunologie en phase clinique, a annoncé sa participation à trois conférences pour investisseurs à venir en septembre 2024. L'entreprise présentera à la 26e Conférence Annuelle Mondiale des Investissements H.C. Wainwright le 11 septembre à 11h30 ET, au Sommet Virtuel sur l'Immunologie et l'Inflammation de Stifel le 17 septembre à 12h00 ET, et à la Conférence Globale sur la Santé de Cantor le 17 septembre à 14h30 ET.
L'équipe de direction de Zura Bio organisera des réunions avec les investisseurs lors de ces événements, le sommet Stifel étant virtuel. Des webdiffusions en direct et des rediffusions des présentations seront disponibles sur le site Internet de l'entreprise pendant au moins 30 jours après chaque événement.
Zura Bio (Nasdaq: ZURA), ein Unternehmen im klinischen Stadium der Immunologie, hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen im September 2024 angekündigt. Das Unternehmen wird am 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright am 11. September um 11:30 Uhr ET, am Stifel-Immunologie- und Entzündungsgipfel (virtuell) am 17. September um 12:00 Uhr ET und an der Cantor Global Healthcare Conference am 17. September um 14:30 Uhr ET präsentieren.
Das Führungsteam von Zura Bio wird während dieser Veranstaltungen Investorenmeetings abhalten, wobei der Stifel-Gipfel virtuell stattfindet. Live-Webcasts und Wiederholungen der Präsentationen werden auf der Unternehmenswebsite für mindestens 30 Tage nach jeder Veranstaltung verfügbar sein.
- None.
- None.
Conference Details:
Event: H.C. Wainwright 26th Annual Global Investment Conference
Details: Presenting on Wednesday, September 11, 2024, at 11:30 a.m. ET and hosting investor meetings in
Event: Stifel Immunology and Inflammation Virtual Summit
Details: Presenting on Tuesday, September 17, 2024, at 12:00 p.m. ET and hosting virtual investor meetings.
Event: Cantor Global Healthcare Conference
Details: Presenting on Tuesday, September 17, 2024, at 2:30 p.m. ET and hosting investor meetings in
Links for live webcasts and replays, if available, will be posted on the News & Events page in the Investors & Media section of the Zura Bio website. Presentations will be archived on the website for at least 30 days following the event.
ABOUT ZURA BIO
Zura Bio is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. Currently, Zura Bio is developing three assets which have completed Phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), crebankitug (ZB-168), and torudokimab (ZB-880), with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases, including systemic sclerosis and other novel indications with unmet needs.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240903983694/en/
Megan K. Weinshank
Head of Investor Relations
ir@zurabio.com
Source: Zura Bio Limited
FAQ
What investor conferences will Zura Bio (ZURA) attend in September 2024?
When and where will Zura Bio (ZURA) present at the H.C. Wainwright conference?
What is the date and time of Zura Bio's (ZURA) presentation at the Stifel Virtual Summit?
When will Zura Bio (ZURA) present at the Cantor Global Healthcare Conference?
How long will Zura Bio's (ZURA) presentation recordings be available on their website?
